DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma
Titel:
DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma
Auteur:
Khouri, Jack Faiman, Beth M Grabowski, Dale Mahfouz, Reda Z Khan, Shahper N Wei, Wei Valent, Jason Dean, Robert Samaras, Christy Jha, Babal K Lazarus, Hillard Campagnaro, Erica L. Malek, Ehsan Reed, Janice Karam, Mary Ann Hamilton, Kimberly Fada, Sherry Kalaycio, Matt Liu, Hien Sobecks, Ronald Saunthararajah, Yogen Chew, Yap Orloff, Mohammed Reu, Frederic J